Publications by authors named "Ivo W Tremont-Lukats"

Background: Fatigue is a common and disabling symptom in people with a primary brain tumour (PBT). The effectiveness of interventions for treating clinically significant levels of fatigue in this population is unclear. This is an updated version of the original Cochrane Review published in Issue 4, 2016.

View Article and Find Full Text PDF

Patients with primary brain tumors often experience seizures, which can be the presenting symptom or occur for the first time at any point along the illness trajectory. In addition to causing morbidity, seizures negatively affect independence and quality of life in other ways, for example, by leading to loss of driving privileges. Long-term therapy with antiepileptic drugs (AEDs) is the standard of care in brain tumor patients with seizures, but the role of prophylactic AEDs in seizure-naive patients remains controversial.

View Article and Find Full Text PDF

Background: Endoscopic resection can be used for removing colloid cysts as a substitute for open craniotomy. Cerebral vasospasm, a possible complication of the craniotomy procedure, has not been reported as a complication of endoscopic removal of colloid cysts.

Case Description: A 58-year-old man developed the worst headache of his life.

View Article and Find Full Text PDF

Background: Lidocaine, mexiletine, tocainide, and flecainide are local anesthetics which give an analgesic effect when administered orally or parenterally. Early reports described the use of intravenous lidocaine or procaine to relieve cancer and postoperative pain. Interest reappeared decades later when patient series and clinical trials reported that parenteral lidocaine and its oral analogs tocainide, mexiletine, and flecainide relieved neuropathic pain in some patients.

View Article and Find Full Text PDF

Background: Repurposed memantine, mefloquine, and metformin have putative anticancer activity. The objective of this phase 1 study was to determine the maximum tolerated doses (MTDs) of combinations of these agents with temozolomide (TMZ).

Methods: Adults with newly diagnosed glioblastoma who completed chemoradiation were eligible.

View Article and Find Full Text PDF

Glioblastoma (GBM) is the most common type of malignant tumor found in the brain, and acts very aggressively by quickly and diffusely infiltrating the surrounding brain parenchyma. Despite its aggressive nature, GBM is rarely found to spread extracranially and develop distant metastases. The most common sites of these rare metastases are the lungs, pleura and cervical lymph nodes.

View Article and Find Full Text PDF

Patients with gliomas are at risk of cerebrovascular accidents (CVA) with potential consequences on survival, function, and local tumor control. Our objective was to provide information about CVA in patients with gliomas and to estimate survival in this group. We reviewed all adult glioma patients with ischemic CVA at the University of Texas-M.

View Article and Find Full Text PDF

Purpose: To describe a patient whose diagnosis of gliomatosis cerebri was delayed for one year due mostly to dexamethasone.

Patients And Methods: A 78-year-old woman was followed in clinic for a year with a brain lesion suspicious but not definitive for glioma, whose clinical course and neuroimaging varied with use of dexamethasone. A first biopsy and MR spectroscopy did not find evidence of malignancy.

View Article and Find Full Text PDF

Sinking skin flap syndrome (SSFS) is a rare neurological complication in patients with traumatic haemorrhage, stroke or cerebral oedema who undergo decompressive craniectomy to relieve increased intracranial pressure. Hallmark of SSFS is the sinking of the scalp to a plane lower than the edges of the skull defect in the setting of neurological deterioration. Our objective is to report that SSFS can present after small craniotomy without cerebral cortex compression and to share our diagnostic/therapeutic approach.

View Article and Find Full Text PDF

In immunocompromised patients, the pulmonary computed tomography halo sign is highly suggestive of angioinvasive aspergillosis. Early recognition may be life-saving.

View Article and Find Full Text PDF

Imaging has become a central part of the evaluation of lesions of the central nervous system. Despite patterns of the appearances of several types of central nervous system malignancies and improving resolution of imaging techniques, there are other processes that can display similar characteristics. Time and again, vascular, inflammatory, and vascular lesions will mimic a neoplastic process, requiring tissue diagnosis.

View Article and Find Full Text PDF
Article Synopsis
  • The standard treatment for newly diagnosed glioblastoma includes temozolomide and radiotherapy, with bevacizumab approved for recurrent cases but its effectiveness in newly diagnosed patients is unclear.
  • In a randomized trial involving 978 patients, those receiving bevacizumab did not show significantly improved overall survival compared to those on placebo, with median survival times of 15.7 and 16.1 months, respectively.
  • However, the bevacizumab group exhibited longer progression-free survival (10.7 months vs. 7.3 months) but also experienced more serious side effects and a decline in quality of life and cognitive function.
View Article and Find Full Text PDF

Background: The etiology of encephalitis presents a diagnostic challenge and often remains a mystery. However, current technological advances using antibodies can enable a definitive diagnosis in cases that would previously have been suspected to be idiopathic or viral encephalitis. Our objective is to show that tonsil neuroendocrine carcinoma can present initially as limbic encephalitis mediated by N-type calcium channel antibodies and to highlight the diagnostic confusion before cancer detection.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigated the combined effect of thalidomide and temozolomide on patients with recurrent glioblastoma multiforme (GBM), focusing on 6-month progression-free survival (6PFS) and safety.
  • A total of 44 patients participated, with 43 evaluable; the treatment showed limited effectiveness, with only a 7% objective response rate and a 24% chance of being progression-free at 6 months.
  • Although the combination was deemed reasonably safe with some reported toxicities, it did not demonstrate significant improvement over temozolomide alone in treating recurrent GBM.
View Article and Find Full Text PDF

Synopsis of recent research by authors named "Ivo W Tremont-Lukats"

  • - Ivo W Tremont-Lukats focuses on neurological conditions, particularly the clinical management of brain tumor-related symptoms such as seizures and fatigue, and the implications of various treatments and interventions in this patient population
  • - His recent research includes evaluations of techniques like arterial spin labeling for better diagnostic differentiation in astrocytoma cases, as well as systematic reviews assessing the effectiveness of interventions for fatigue in adults with primary brain tumors
  • - Tremont-Lukats also addresses emerging issues in neurology, including the neurological sequelae of COVID-19 and the controversies surrounding the prophylactic use of antiepileptic drugs in glioma patients, suggesting a comprehensive approach to the multifaceted challenges posed by brain tumors